GGrantIndex
← Search

Advanced Development of Therapeutic Products for Antibiotic Resistant Bacteria

$3,511,044N01FY2023AINIH

Crestone, Inc., Boulder CO

Investigators

Abstract

To support the advanced development of a promising candidate therapeutic. The research and development activities to be supported will allow the candidate therapeutic product to progress along the product development pathway, and include preclinical and IND enabling development activities, and clinical safety and efficacy assessment.

View original record on NIH RePORTER →